In order to access this content you must be logged in and have a subscription to PL Intelligence.
PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Myriad Genetics forms alliance with Biotecne for familial disease genomics
Myriad Genetics, Abbott form drug discovery collaboration
Myriad Genetics Selects Lundbeck as European Partner for Flurizan
Myriad Genetics acquires cancer drug
Myriad Genetics forms new subsidiary to develop lead compounds
Myriad Genetics and Abbott expand collaboration
Maxim Pharmaceuticals licenses novel cancer therapeutic candidate to Myriad Genetics
Epimmune to receive milestone payment from Searle
Myriad Genetics Acquires Novel Therapeutic Drug Management Technology from Saladax Biomedical
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
